Ratings Alignment Healthcare, Inc.

Equities

ALHC

US01625V1044

Managed Healthcare

Real-time Estimate Cboe BZX Other stock markets 19:11:57 16/07/2025 BST			5-day change	1st Jan Change
13.43 ^USD	+1.28%		-3.56%	+19.16%

07-15	Alignment Healthcare Insider Sold Shares Worth $403,347, According to a Recent SEC Filing	MT
07-08	Alignment Healthcare Wins Favorable Court Ruling, Arizona HMO Star Rating Raised	MT

Summary: Alignment Healthcare, Inc.

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Highlights: Alignment Healthcare, Inc.

According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
The company shows low valuation levels, with an enterprise value at 0.65 times its sales.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
For several months, analysts have been revising their EPS estimates roughly upwards.
Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Historically, the company has been releasing figures that are above expectations.

Weaknesses: Alignment Healthcare, Inc.

As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
Low profitability weakens the company.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The company is highly valued given the cash flows generated by its activity.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings Chart: Alignment Healthcare, Inc.

Source: Surperformance

ESG chart: Alignment Healthcare, Inc.

Source: MSCI

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Global Valuation (Composite)	Capi.($)
ALIGNMENT HEALTHCARE, INC.	-	2.62B
UNITEDHEALTH GROUP INC.		265B
CIGNA		80.79B
ELEVANCE HEALTH, INC.		75.96B
HUMANA INC.		26.78B
CENTENE CORPORATION		14.93B
MOLINA HEALTHCARE, INC.		11.63B
PROGYNY, INC.		1.99B
CLOVER HEALTH INVESTMENTS, CORP.	-	1.52B
Average		53.43B
Weighted average by Cap.

See all sector ratings

Investor (Composite)

Trader (Composite)

ESG MSCI

Financials

Revenue growth

EPS growth

Capital Efficiency (Composite)

Net Margin

Financial Health (Composite)

Valuation

P/E

EV/Revenue

EV/EBITDA

PBR

Dividend Yield

Revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

Revenue revisions (1 month)

EPS revisions (1 year)

EPS revisions (4 months)

Consensus

Analysts' buy/sell recommendations

Analysts' recommendations evolution (4 months)

Analysts' target price

Analysts' target price evolution (4 months)

Analysts' target price evolution (1 year)

Business Predictability

Surprise rates

Analysts' coverage

Analysts' recommendations divergence

Analysts' Target price divergence

Financial estimates divergence

ESG

Environment

Social

Governance

Controversy

Ethical controversies

Human rights controversies

Tax subsidies controversies

Sharia compliant

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes